ReviewInternational journal of legal medicine2026
Postmortem interval estimation through skeletal muscle protein degradation: a comprehensive review.
Review in International journal of legal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postmortem interval (PMI) estimation is a pivotal challenge in forensic science, and skeletal muscle protein degradation has emerged as a promising biochemical tool. In this review, we conducted a comprehensive literature search of PubMed for studies published between 2014 and 2024 using keywords related to PMI estimation and protein/proteomics. Of the 287 results retrieved, 81 were available as free full-text articles, and 17 met the inclusion criteria focusing on skeletal muscle protein. The most used techniques were Western blotting, followed by mass spectrometry and immunohistochemistry. Frequently studied proteins included eEF1A2, desmin, GAPDH, α-actinin, vinculin, α-tubulin, and tropomyosin. Although protein degradation in muscle tissue shows significant potential for PMI estimation, relying on a single protein or a small group of proteins is insufficient due to variability introduced by environmental, individual, and species-specific factors. The study highlights the need for long-term, semi-controlled studies using human tissue, as well as further investigation of new candidate biomarkers and the stability of established markers across diverse PMI ranges and conditions. Comparative studies between animal and human data are vital for understanding species differences and ensuring reliable extrapolation. Moving forward, interdisciplinary and methodologically standardized approaches will be critical for integrating protein-based findings into routine forensic practice and achieving a robust, multifactorial method for PMI estimation.
Indexed as
Identifiers
41483101What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.